Delivery Order SPE2DB22D1017-SPE2DB25FF3FT
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,414.61, is a Firm Fixed Price Delivery Order for the supply of SKYRIZI 150 MG/ML PENML medical products. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $77,040.74, is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price and the ultimate completion date is October 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government has awarded a Delivery Order contract worth $49,855.73 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and covers the procurement of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $21,889.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 150 MG/ML PENML, a specialty medication, with a completion date of December 15, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $27,466.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication, with a completion date of December 20, 2024. The contract has a firm fixed-price pricing type and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,171.71 firm fixed-price delivery order contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $32,752.46 fixed-price contract is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has a period of performance through November 2024 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $18,260.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product SKYRIZI 150 MG/ML PENML, with a completion date of January 17, 2025. The contract is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $12,236.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty medication, with a completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,568.31, is for the delivery of SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...